CELLMAX TAIWAN CO. LTD.
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
1. FirstSight
2. CMx Platform
2. CMx Platform
The content above was translated by Ai
Founded Year
2012
Unified Business No.
53737681
Status
Active
Number of Employees
32
Total Paid-in
Capital
151,500,000 (NT$)
Location of Company
Taiwan
, New Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
CellMax Life is a biotechnology company that is revolutionizing early cancer detection and prevention. The company’s product portfolio includes a blood test that can detect cancer before it is too late. CellMax Life was founded in 2013 and is based in California, the United States. The company has offices in Silicon Valley (U.S.) and Taiwan and isfunded by a venture capital firm in the U.S. and technology industrialists in Taiwan.
The content above was translated by Ai
